MyCardium AI, a UCL spinout founded in April 2022, is leading the way in advancing cardiac diagnostics with “super-human” AI technology. Specializing in both EchoConfidence and 1CMR AI solutions, we provide hospitals and clinics with advanced tools to enhance echocardiography and cardiac MRI analysis. Our ISO 13485-accredited software, enables clinicians to deliver more accurate diagnoses and improve healthcare outcomes. By automating heart measurements with super-human precision, our AI supports next-generation treatments while increasing efficiency in image interpretation. Backed by our specialized core lab services, MyCardium AI aims to deliver this technology to over 2,000 point-of-care centers globally.

Recognized by awards from Tech Climbers and the Merseyside Independent Business Awards, we are committed to driving innovation and excellence in healthcare technology.